Cargando…

Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy

BACKGROUND: Pleural effusion is a common clinical condition caused by several respiratory diseases, including tuberculosis and malignancy. However, rapid and accurate diagnoses of tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE) remain challenging. Although monocytes have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Lisha, Deng, Shuanglinzi, Tang, Wei, Hu, Xinyue, Yin, Feifei, Ge, Huan, Tang, Jiale, Liao, Zhonghua, Feng, Juntao, Li, Xiaozhao, Mo, Biwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396188/ https://www.ncbi.nlm.nih.gov/pubmed/35819097 http://dx.doi.org/10.1002/jcla.24579

Ejemplares similares

Recruitment of IL‐1β‐producing intermediate monocytes enhanced by C5a contributes to the development of malignant pleural effusion
por: Luo, Lisha, et al.
Publicado: (2022)

Anaphylatoxins orchestrate Th17 response via interactions between CD16(+) monocytes and pleural mesothelial cells in tuberculous pleural effusion
por: Deng, Shuanglinzi, et al.
Publicado: (2021)

Complement regulatory proteins: Candidate biomarkers in differentiating tuberculosis pleural effusion
por: Tang, Huan, et al.
Publicado: (2023)

CX3CL1-induced CD16(+) monocytes extravasation in myeloperoxidase-ANCA-associated vasculitis correlates with renal damage
por: Tang, Jiale, et al.
Publicado: (2022)

GLCCI1 Deficiency Induces Glucocorticoid Resistance via the Competitive Binding of IRF1:GRIP1 and IRF3:GRIP1 in Asthma
por: Hu, Xinyue, et al.
Publicado: (2021)

Altered circulating CCR6(+)and CXCR3(+) T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis
por: Liao, Zhonghua, et al.
Publicado: (2021)

Respiratory Syncytial Virus Exacerbates Kidney Damages in IgA Nephropathy Mice via the C5a-C5aR1 Axis Orchestrating Th17 Cell Responses
por: Hu, Xinyue, et al.
Publicado: (2019)

Corrigendum: Respiratory Syncytial Virus Exacerbates Kidney Damages in IgA Nephropathy Mice via the C5a-C5aR1 Axis Orchestrating Th17 Cell Responses
por: Hu, Xinyue, et al.
Publicado: (2019)

Identification of potential biomarkers and immune infiltration characteristics in severe asthma
por: Jiang, Yuanyuan, et al.
Publicado: (2022)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Malignant pleural effusions: Differentiating pelvic malignancies
por: Sharma, Mukesh, et al.
Publicado: (2015)

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion
por: Shan, Yi, et al.
Publicado: (2017)

Immune Regulation of Interleukin-27 in Malignant Pleural Effusion
por: Li, Shi, et al.
Publicado: (2015)

An Update in the Management of Malignant Pleural Effusion
por: Muduly, DK, et al.
Publicado: (2011)

Ferritin Assay in Malignant Pleural Effusion
por: Chung, Won-Tae, et al.
Publicado: (1987)

Primary malignant myelomatous pleural effusion
por: Mangla, Ankit, et al.
Publicado: (2016)

Pleural procedures in the management of malignant effusions
por: Ferreiro, Lucía, et al.
Publicado: (2017)

Management of Septated Malignant Pleural Effusions
por: Banka, Radhika, et al.
Publicado: (2018)

Malignant Pleural Effusion: Diagnosis and Management
por: Ferreiro, Lucía, et al.
Publicado: (2020)

Surgical treatment in malignant pleural effusion
por: Karadayı, Şule, et al.
Publicado: (2021)

Malignant pleural effusion diagnosis and therapy
por: Yang, Liangliang, et al.
Publicado: (2023)

Clinical identification of malignant pleural effusions
por: Jia, Jianlong, et al.
Publicado: (2023)

Diagnostic value of medical thoracoscopy in malignant pleural effusion
por: Wu, Yan-Bing, et al.
Publicado: (2017)

Implantation of permanent pleural catheter for palliation of malignant pleural effusion
por: Meier, Michelle, et al.
Publicado: (2016)

Accuracy of closed pleural biopsy in the diagnosis of malignant pleural effusion
por: Báez-Saldaña, Renata, et al.
Publicado: (2017)

The diagnostic value of pleural fluid homocysteine in malignant pleural effusion
por: Santotoribio, Jose D., et al.
Publicado: (2019)

Indwelling pleural catheters for malignant pleural effusion – Are we ready?
por: Patel, Dharmesh, et al.
Publicado: (2022)

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
por: Chen, Kuan-Yuan, et al.
Publicado: (2016)

BCG treatment of malignant pleural effusions in the rat.
por: Pimm, M. V., et al.
Publicado: (1976)

DR-70 immunoassay and malignant pleural effusion
por: Joob, Beuy, et al.
Publicado: (2014)

Malignant pleural effusion from prostate adenocarcinoma
por: Knight, James C., et al.
Publicado: (2014)

Diagnosis and management options in malignant pleural effusions
por: Dixit, Ramakant, et al.
Publicado: (2017)

Management of malignant pleural effusion: challenges and solutions
por: Penz, Erika, et al.
Publicado: (2017)

Microbiome profile associated with malignant pleural effusion
por: Shojaee, Samira, et al.
Publicado: (2020)

Histiocytic pleural effusion: the strong clue to malignancy
por: Chae, Ganghee, et al.
Publicado: (2021)

Management of Pleural Effusion Secondary to Malignant Mesothelioma
por: Musso, Valeria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ub7dcss69t03t57r7jdkvfi7vl